High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed
Completed · Phase 2
Conditions studied: Colorectal Cancer
In brief
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of folic acid may be an effective way to prevent colorectal cancer in patients with polyps that have been surgically removed. PURPOSE: Randomized phase II trial to study the effectiveness of high-dose folic acid in preventing colorectal cancer in patients who have had polyps surgically removed within 18 months of the trial.
Key facts
- Study ID
- NCT00002650
- Run by
- Eastern Cooperative Oncology Group
- People needed
- 80
- Starts
- 1995-06-12
- Expected to finish
- 2009-05-01
- Last updated by the study team
- 2023-06-22
Who can join
Age: 21 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University — Chicago, Illinois, United States
- Veterans Affairs Medical Center - Lakeside Chicago — Chicago, Illinois, United States
- New England Medical Center Hospital — Boston, Massachusetts, United States
- USDA Human Nutrition Research Center — Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- Veterans Affairs Medical Center - New York — New York, New York, United States
- NYU School of Medicine's Kaplan Comprehensive Cancer Center — New York, New York, United States
- CCOP - Marshfield Medical Research and Education Foundation — Marshfield, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.